SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-092281
Filing Date
2024-08-07
Accepted
2024-08-07 08:00:24
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nams-20240630.htm   iXBRL 10-Q 1909390
2 EX-10.1 nams-ex10_1.htm EX-10.1 254569
3 EX-10.2 nams-ex10_2.htm EX-10.2 44249
4 EX-31.1 nams-ex31_1.htm EX-31.1 15736
5 EX-31.2 nams-ex31_2.htm EX-31.2 15693
6 EX-32.1 nams-ex32_1.htm EX-32.1 8429
7 EX-32.2 nams-ex32_2.htm EX-32.2 8403
8 GRAPHIC img55788779_0.jpg GRAPHIC 8836
  Complete submission text file 0000950170-24-092281.txt   6534371

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nams-20240630.xsd EX-101.SCH 947302
64 EXTRACTED XBRL INSTANCE DOCUMENT nams-20240630_htm.xml XML 754278
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41562 | Film No.: 241181500
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)